The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: Results from a historical cohort study

Thrombosis and Haemostasis

Volumn 79, Issue 1, 1998, Pages 19-22

  Rajan, Raghu ^b   Levine, Mark ^a   Gent, Michael ^b   Hirsh, Jack ^b   Geerts, William ^b   Skingley, Peter ^b   Julian, Jim ^b  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANUS CANCER; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLON CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

EID: 0031974361     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614211     Document Type: Article

References (12)

1. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Ca Med Rev 1992; 11: 237-48.
2. Goldberg RJ, Seneff M, Gore JM et al. Occult malignant neoplasm in patients with deep vein thrombosis. Arch Intern Med 1987; 147: 251-3.
3. Griffin MR, Stanson AW, Brown ML et al. Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasm. Arch Intern Med 1987; 147: 1907-11.
4. Cornuz J, Pearson SD, Creager Ma, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Inter Med 1996; 125: 785-93.
5. Monreal M, Lafoz E, Casals A et al. Occult cancer in patients with venous thrombosis: a systematic approach. Cancer 1991; 67: 541-5.
6. Aderka D, Brown A, Zelikovski A, Pinkas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 1986; 57: 1846-9.
7. Prandoni P, Lensing AW, Büller HR et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
8. Nordstrom M, Linblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep vein thrombosis and occult malignancy: an epidemiological study. BMJ 1994; 308: 891-4.
9. Levine MN, Hirsh J, Gent M et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606-11.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
11. Cox DR. Regression models and life tables. J Royal Stat Soc B 1972; 34: 187-220.
12. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Early diagnosis: In: Clinical Epidemiology A Basic Science for Clinical Medicine. Little, Brown, Boston pp 153-70.